Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000778265 | SCV000914438 | uncertain significance | Leigh syndrome | 2018-10-25 | criteria provided, single submitter | clinical testing | The COX15 c.784C>T (p.Arg262Ter) variant is a stop-gained variant that is predicted to result in a premature termination of the protein. A literature search was performed for the gene and cDNA change. No publications were found based on this search. The variant is reported at a frequency of 0.000015 in the African population of the Genome Aggregation Database. Due to the potential impact of stop-gained variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for mitochondrial respiratory chain complex IV deficiency. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. |
Labcorp Genetics |
RCV002535631 | SCV003312791 | pathogenic | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg262*) in the COX15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in COX15 are known to be pathogenic (PMID: 15863660, 21412973). This variant is present in population databases (rs774366079, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with COX15-related conditions. ClinVar contains an entry for this variant (Variation ID: 631620). For these reasons, this variant has been classified as Pathogenic. |